Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;14(11):e202100117.
doi: 10.1002/jbio.202100117. Epub 2021 Aug 15.

Near-infrared emissive polymer-coated IR-820 nanoparticles assisted photothermal therapy for cervical cancer cells

Affiliations

Near-infrared emissive polymer-coated IR-820 nanoparticles assisted photothermal therapy for cervical cancer cells

Lijun Zhu et al. J Biophotonics. 2021 Nov.

Erratum in

Abstract

Photothermal therapy (PTT) has attracted wide attention due to its noninvasiveness and its thermal ablation ability. As photothermal agents are crucial factor in PTT, those with the characteristics of biocompatibility, non-toxicity and high photothermal stability have attracted great interest. In this work, new indocyanine green (IR-820) was utilized as a photothermal agent and near-infrared (NIR) fluorescence imaging nanoprobe. To improve the biocompatibility, poly(styrene-co-maleic anhydride) (PSMA) was utilized to encapsulate the IR-820 molecules to form novel IR-820@PSMA nanoparticles (NPs). Then, the optical and thermal properties of IR-820@PSMA NPs were studied in detail. The IR-820@PSMA NPs showed excellent photothermal stability and biocompatibility. The cellular uptaking ability of the IR-820@PSMA NPs was further confirmed in HeLa cells by the NIR fluorescent confocal microscopic imaging technique. The IR-820@PSMA NPs assisted PTT of living HeLa cells was conducted under 793 nm laser excitation, and a high PTT efficiency of 73.3% was obtained.

Keywords: IR-820; NIR emission; cervical cancer; photothermal therapy.

PubMed Disclaimer

References

REFERENCES

    1. W. Xue, W. Lizhe, Z. Shan, Q. Renna, L. Shi, Biomater. Sci. 2019, 7, 3846.
    1. S. Zhang, H. Xu, L. Zhang, Y. Qiao, Chin. J. Cancer Res. 2020, 32, 720.
    1. W. Small, M. A. Bacon, A. Bajaj, L. T. Chuang, B. J. Fisher, M. M. Harkenrider, A. Jhingran, H. C. Kitchener, L. R. Mileshkin, A. N. Viswanathan, D. K. Gaffney, Obstet. Gynecol. Surv. 2017, 72, 2404.
    1. J. A. Gadzinski, J. Guo, B. J. Philips, P. Basse, E. K. Craig, L. Bailey, J. Latoche, J. T. Comerci, J. L. Eiseman, Adv. Biolog. Chem. 2016, 6, 193.
    1. P. T. Ramirez, M. Frumovitz, R. Pareja, A. Lopez, M. Vieira, R. Ribeiro, A. Buda, X. Yan, Y. Shuzhong, N. Chetty, D. Isla, M. Tamura, T. Zhu, K. P. Robledo, V. Gebski, R. Asher, V. Behan, J. L. Nicklin, R. L. Coleman, A. Obermair, N. Eng. J. Med. 2018, 379, 1895.

Publication types